Trial
NCT03979664
Iontophoresis in Psoriasis
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Psoriasis
Intervention
Activapatch intellidose 2.5 using active Iontophoresis
Why stopped
FDA did not provide approval of the use of the drug for the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-01